Hypersensitivity Type I


atopic/allergic individuals;
     IgE: produced after contact with low levels of innocuous environmental
allergens
  IgE¡ª¡ª¡ª¡ªmast cells ¡ª¡ª¡ª¡ª¡ª¡ærelease mast cell mediators(autocoids,  
       bind              via Fc RI
                                  cytokines)                                 
     
  IgE produced is due to a genetic predisposition to make TH2/Il-4 type immune
response to allergen
  This response can be considered an unfortunate side effects of its activity
                                                                           

hypersensitivity: adaptive immune response occurs in an - exaggerated  -  form
                                                                  
                                                   - inappropriate -
              ¡ª¡ª¡æ  inflammator reaction
               cause     tissue damage
  
         -antibody-mediated: type I, II, III
         -mediated mainly by  T cell      -   :type IV
                                           
                            macrophages-
        type I(immediate)
        :innocuous environmental antigens ¿¡ IgE°¡ response ÇÒ ¶§
        ¡æIgE-sentsitized mast cell
        ¡ærelease pharmacological mediators(fig. 22.3)
       type II(antibody-dependent cytotoxic hypersensitivity)
        :antobody¡ª¡ª¡ª¡ªself antigen
                  bind  
  

                       foreign antigen
        ¡æphagocytosis
          killer cell activity
          complement-mediated lysis
        type III
        i)immune complex°¡ large quantities Çü¼º
        ii) reticuloendothelial system¿¡ ÀÇÇØ clearµÇÁö ¾ÊÀ½       
                 ¡æserum-sickness type reaction
       type IV(delayed type hypersensitivity)                   
         :most serious
         :antigens ¡ª trapped in ¡ª macrophage ¡ª¡ª¡ª¡æ cannot cleared
        
           T cell stimulated
                 ¡é
          elavorate cytokines
                 ¡é
        inflammatory response

¡áImmunoglobulin E
APCs ÀÇ antigen-presenting/ TH2 cell °úÀÇ cooperation
¡æB cell stimulate
¡æIgE production
¡æIgE response is a local event occurring at the site of the allergen's entry into
the body
      ¡é
  locally produced
      ¡é
  enter circulation
      ¡é
binds to specific receptors on both circulating basophils and tissue-fixed mast cells
: IgE half life
    - free form: only a few days
    - mast cell binding form: many months
:
              irradiated
       IgE response  , prolonged
                             
 thymectomized               thymocytes/spleen cells  from ascaris-primed cell
                     IgE production suppress
                     (¡ñtransferred cell population ÀÇ suppressor T cell¶§¹®)

: TH cell ¿¡¼­ ³ª¿À´Â cytokine ÀÌ IgE production regulate(fig. 22.5)
¡ª¡ª¡æ cytokines produced by TH2 cells
       (IL-3,4,5,9.13) is encoded in a *gene cluster on chromosome 5 in humans and
chromosome 13 in mice

¡áGenetics of the allergic response in mice
:allergic parents¡ª¡æ allergic child
¡Å genetic mechanism
       regulate - total IgE levels
                 - allergen-specigic response
                 -general hyperresponsiveness
 IgE levels
IL-4/another genes, regulates total(but not specific) IgE levels
 genes controlling the allergen-specific response are linked to HLA

¡ámast cells
      morphological differences
          -CTMC(Connective Tissue Mast Cells): blood vessel
          -MMC( Mucosal Mast Cells):highest concentration  mucosa of the midgut
and in the lung

<differences between mast-cell populations-I>


<differences between mast-cell populations-II>

 mast cell proteases
: tryptase, /chymase   asthma ÀÇ hallmark
                 
fibroblast growth factor  
 bronchial mucosal surface is the first site of contact for inhalled allergen
  locally applied corticosteroids also suppress the increase in nasal mast-cell
numbers
¡Åcorticosteroids inhibit cytokine production by TH cells

 IgE ¿¡ binding ÇÏ´Â ´Ù¸¥ cell

allergen
                     IgE cross-linking to mast cell
other molecules
                      aggregation of the Fc  receptor
                      influx of calcium ions into the cell
                      degranulation
                             i) exocytosis of granule contents with the release
of preformed mediators(ex: histamine)
                             ii) induction of synthesis of newly formed
mediators(fig 22.14 22.20)
          
¡áCutaneous Reactions
-skin prick test
-skin patch test

¡áBronchial Reactions

¡áFactors involved in the development of allergy
-genetic disposition ¿Ü¿¡µµ allergy developing factor´Â ¸¹´Ù
<T-cell deficiency, environmental pollutants>
 T-cell deficiency is associated with atopy
:reduced T-cell response in vitro correlate with reduced cell-mediated immunity which
may be reflected in vivo as depressed delayed hypersensitivity
 environmental pollutants act to increase antigen-specific IgE
        ¡é
increase mucosal permeability
enhance allergen entry

¡áHyposensitization
:hyposensitization therapy ; injection of increasing doses of allergen
¡æincrease in serum levels of allergen-specific IgG and suppressor T-cell activity


Hypersensitivity-Type II
                                     
i) caused by (IgG/IgM) against (cell suface/extracellular matrix antigens)
ii) transfection reactions to erythrocytes
iii) antibody       cells/ tissues     
             damage                 by activating complement
iv) haemolytic disease   (maternal antibodys      destroy the fetal
erythrocytes
v) antibody-basement membrane
            intercellular adhesion molecules
            receptor
         tissue damage
                                     
:damage is restricted to the specific cells or tissues bearing the ahtigens

¡áMechanisms of Damage
: antibody directed against cell surface or tissue antigens interacts with complement
and a variety of effector cells to bring about damage to the target cells
: antibody attach surface of cell/tissue.
¡ª¡ª¡æ bind and active complement component c1
¡ª¡ª¡æ i) C3a, C5a ; attract macrophages and polymorphs to the site
                   ; stimulate mast cells and basophils
                     ¡æ produce molecule(attract and activate other effector cells)
       ii) deposition of C3b, C3bi, C3d
       iii) classical component pathway and lytic pathway
          ¡æ production of the C5b-9 membrane attack complex
: complement fragment/IgG
   ¡æ opsoninsÀ¸·Î ÀÛ¿ë
   ¡æ phagocyte °¡ take up
     (by ; lysosomal activity¸¦ ³ôÀÓ
          ¡æreactive oxygen intermediates production)
        

  ¡æ hypersensitivity type II

 

 


¡ØNEUTROPHIL ACTIVATION

      
¡áReactions against Blood cells and Platelets


<1> transfusion reaction occur when a recipient has antibodies that react against
donor erythrocytes
      : blood group system consists of a gene locus that specifies an antigen on
the surface of blood cells
      
         ¡Å transfusion of allogenic(nonself) erythrocytes into an individual who
already has antibodies against them may produce erythrocyte destruction
and symptoms of a transfusion reaction

         ¡Å the aim of cross-matching is to ensure that the blood of a recipient
does not contain antibodies that will be able to react with and destroy
transfused erythrocytes
    ABO system antibody ¡æ IgM (´ë´Ù¼ö )
            ¡æ cause agglutination
               complement activation
               intravascular haemolysis
    other blood group ¡æ induce IgG
               ¡æ less agglutination
                  take up by phagocytes
               ¡æ circulatory shock À¯¹ß
<2> haemolytic disease of the newborn is due to maternal IgG antibodies which react
against the child's erythrocytes in utero
<3> autoimmune haemolytic anaemias arise spontaneously as autoimmune disease or
may be induced as reaction to drugs
      :patients prodece antibodies to their own erythrocytes
        -warm-

reactive autoantibodies
        -cold-reactive autoantibodies
        -antibodies provoked by allergic reaction to drugs

¡áReactions against Tissue Antigens
:antigen are extracellular, and may be expressed on structural proteins or on the
surface of cells
-Goodpasture's syndrome
-Pemphigus
-Myasthenia gravis